Lycorine inhibits glioblastoma multiforme growth through EGFR suppression

BACKGROUND: Lycorine has been revealed to inhibit the development of many kinds of malignant tumors, including glioblastoma multiforme (GBM). Although compelling evidences demonstrated Lycorine’s inhibition on cancers through some peripheral mechanism, in-depth mechanism studies of Lycotine’s anti-G...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jia, Zhang, Tao, Cheng, Zheng, Zhu, Ni, Wang, Hua, Lin, Li, Wang, Zexia, Yi, Haotian, Hu, Meichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050662/
https://www.ncbi.nlm.nih.gov/pubmed/30016965
http://dx.doi.org/10.1186/s13046-018-0785-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050662/
https://www.ncbi.nlm.nih.gov/pubmed/30016965
http://dx.doi.org/10.1186/s13046-018-0785-4

Ejemplares similares